Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.68EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.65 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.466EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
L.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.339EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.229EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.415EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.370EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.421EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.612EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.305EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
CH.1.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LQ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MD.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MB.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
unclassifiableEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KS.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used